Folic acid antagonists increase risk of congenital defects

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1267, 2000-01, pp. : 20-20

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

In utero valproic acid exposure may increase risk of congenital disorders

By  

Inpharma, Vol. 1, Iss. 1485, 2005-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Primary Prevention of Neural-Tube Defects and Some Other Major Congenital Abnormalities: Recommendations for the Appropriate Use of Folic Acid During Pregnancy

By Czeizel A.E.  

Pediatric Drugs, Vol. 2, Iss. 6, 2000-11 ,pp. : 437-449

Adis International

Access to resources Recommend Favorite

Risk of miscarriage not increased with folic acid

By  

Inpharma, Vol. 1, Iss. 1305, 2001-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

TNF antagonists increase risk of serious infection

By  

Inpharma, Vol. 1, Iss. 1393, 2003-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Increased colorectal adenoma risk with folic acid?

By  

Reactions Weekly, Vol. 1, Iss. 1156, 2007-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite